Continuing Medical Education (CME's) are accredited studies physicians are required to complete to keep current with medical procedures and treatment options.
Below is a list of continuing medical education studies I completed during the past years. The courses listed validate my knowledge in the evaluation and management of both cardiovascular risk factors and women’s health.
Coronary Heart Disease Risk: Women’s Health Initiative, .50 AMA/PRA credit
New Trail Results on the Risk/Benefit of Postmenopausal Hormone Replacement Therapy and Cardiovascular Disease, 1.0 AMA/PRA credit
C-Reactive Protein, Metabolic Syndrome and Cardiovascular Events
in Women, .50 AMA/PRA credit
Pathways from Insulin Resistance to Cardiovascular Disease, 1.75 AMA/PRA credit
Preventing Diabetes in the Prediabetic, 1.0 AMA/PRA credit
Diabetes Update 2003: Keys to Control, 3.00 AMA/PRA credit
Management of Obesity, 2.0 AMA/PRA credit
Assessment & Management of Adult Obesity, 4.0 AMA/PRA credit
The Epidemic of Pediatric Obesity, 3.0 AMA/PRA credit
Metabolic Syndrome: Review, 2.0 AMA/PRA credit
Cholesterol Management & the Concept of Dual Inhibition, 3.0 AMA/PRA credit
Glycemic Control Slows Rates of Carotid Artery Disease Progression, .50 AMA/PRA credit
Collaborative Atorvastatin Diabetes Study, 50 AMA/PRA credit
AHA/CDC Scientific Statement on C-Reactive Protein & other Inflammatory Markers, .50 AMA/PRA
New Studies Evaluate Outcomes with Early Statin Use in the Setting of Acute Coronary Events, 1.0 AMA/PRA credit
Reversal of Atherosclerosis with Aggressive Lipid Lowering, .50 AMA/PRA credit
Pravastatin or Atorvastatin and Infection Therapy, .50 AMA/PRA credit
The Patient with a Statin Intolerance, .50 AMA/PRA credit
New Advances in Stroke Management, 3.00 AMA/PRA credit
New Directions in the Treatment of Peripheral Artery Disease, 1.75 AMA/PRA credit
ACE/ARB or both: What clinical Trails Tell Us, 1.0 AMA/PRA credit
A Guide to Recently Approved Cardiovascular Medications, 1.0 AMA/PRA credit
PPAR’s as Therapeutic Targets in T2DM and Atherosclerosis, 2.0 AMA/PRA credit
Integrating Metabolism, Inflammation and CVD: Translating Emerging Science into Clinical Practice, 2.25 AMA/PRA credit
Altering Clinical Outcomes in T2DM, 1.0 AMA/PRA credit
Therapeutic Strategies for CV Risk Reduction in Metabolic Syndrome, 1.50 AMA/PRA
Carotid Artery Stenting, Intro to Carotid Artery Disease and Stroke, Diagnosis of Carotid Artery Disease, Treatment of Carotid Artery Disease, Carotid Stenting Procedure, 3.50 AMA/PRA credit
Enhanced Case Study III: Middle Aged Female with CVD and Uncontrolled
Hypercholesterolemia Assessed for LDL Apheresis, 2.0 AMA/PRA credit
Enhanced Case Study IV: Unique CHD Risk Factors in the South Asian Patient, 2.0 AMA/PRA credit
Lipidhealth.org 2004/05 Winter Newsletter Posttest, 1.0 AMA/PRA credit
Nitric Oxide and Oxidative Stress: Exploring New Directions, 1.0 AMA/PRA credit
Visions of Atherosclerosis in T2DM: The Case for Early Intervention, 2.0 AMA/PRA credit
A Critical Appraisal of Dyslipidemia Therapy, 2.0 AMA/PRA credit
A Review of Extended Cycle Oral Contraceptives, 1.0 AMA/PRA credit
The Contraception Report, Vol 14, 1.0 AMA/PRA credit
Maximizing Contraceptive Success, .75 AMA/PRA credit
Contraceptives for Adolescents, .50 AMA/PRA credit
Fifty Years of Family Planning, 1.0 AMA/PRA credit
Emergency Contraception, .75 AMA/PRA credit
In Office Evacuation: Surgical/Medical, 1.0 AMA/PRA credit
The Today Sponge Prepare for its Return to the U.S. 1.0 AMA/PRA credit
Oral Contraceptives and Smoking, .75 AMA/PRA credit
IUD’s and Special Populations, 1.5 AMA/PRA credit
Bacterial Vaginosis, 1.75 AMA/PRA
Avoiding Osteoporotic Fractures, 1.0 AMA/PRA credit
Osteoporosis, 3.0 AMA/PRA credit
State of the Art Management of Osteoporosis, 4.0 AMA/PRA credit
Breast Cancer Genetic Testing, 2.0 AMA/PRA credit
What’s the Best Approach to Hyperprolactinemia, 1.0 AMA/PRA credit
Infertility, 2.0 AMA/PRA credit
Preconception Care, 1.50 AMA/PRA credit
In Office Assessment of Urinary Incontinence. 1.0 AMA/PRA credit
Black Cohosh use in Menopause, 1.5 AMA/PRA credit
Soy Protein and Breast Cancer, 1.50 AMA/PRA credit
Strategies for Meeting the Needs of Today’s Women During Menopause, 3.25 AMA/PRA credit
Recommendations for Estrogen/Progesterone Use in Peri and Postmenopausal Women: October 2004 position statement of The North American Menopause Society, .50 AMA/PRA credit
Examination of Extended Hormonal Contraception to Reduce Bleeding, 1.0 AMA/PRA credit
How, when and why to Manage Cervical Dysplasia in Adolescents, 1.0 AMA/PRA credit
Premenstrual Dysphoric Disorder, .50 AMA/PRA credit
Treatable and Preventable STIs in Young Women, 1.0 AMA/PRA credit
Polycystic Ovary Syndrome, 1.0 AMA/PRA credit
Issues & Answers in Hormone Therapy, 1.0 AMA/PRA credit
Estrogen Deficiency during Menopause, case one (Metabolic Syndrome), 1.0 AMA/PRA credit
Estrogen Deficiency during Menopause, case two, (Low bone density in Asymptomatic Women without Osteoporosis) 1.0 AMA/PRA credit
Forum: Prevention & Treatment of Osteoporosis,
Screening for Cervical Cancer and Precancerous Lesions,
Metabolic Syndrome in Women: A clinical challenge, 1.75 AMA/PRA credit
Forum: Progestins used in Contraception, The Complicated Issue of Obesity,
The Impact of Obesity on Mortality & Health, 1.75 AMA/PRA credit
Continuing Medical Education Credits completed 2006
Nutritional Influences on Bone Health:
An Update on Current Research &Clinical Implications 1.8 AMA/PRA
Role and Importance of Calcium in Preventing and Managing Osteoporosis 1.25 AMA/PRA
Osteoporosis Guidelines Updated 0.5 AMA/PRA
Updated Position Statement for Calcium Intake in Postmenopausal Women 0.25 AMA/PRA
Contraception Today: Risks and Benefits in Scientific,
Clinical, and Sociocultural Context 0.75 AMA/PRA
AAP Issues Guidelines for Menstrual Cycle Evaluation 0.25 AMA/PRA
When Should You Treat For Mild Hypothyroidism 1.0 AMA/PRA
An Eviddence Based Review of Herbal Therapies and DHEA Supplementation
for the Treatment of FSD 1.0 AMA PRA
Maximizing Contraceptive Service Delivery 1.0 AMA PRA
Standard Days Method 2.4 AMA/PRA training course
Explaining Ovulation Awareness Based Family Planning Methods 1.0 AMA PRA
Natural Family Planning 1.0 AMA PRA
Cardiovascular Disease & Women: Putting Prevention into Practice 1.5 AMA/PRA
Diabetes, Metabolic Syndrome and Very Low Cholesterol:
The Treating to New Targets (TNT) Study 0.5 AMA/PRA
The Insidious Metabolic Syndrome: Diagnosis and Treatment 1.0 AMA/PRA
Analysis of Latest Trial Data Points to New Guidelines and Restructured
Hypertension Therapy 1.0 AMA/PRA
Is There an Intrinsic Vascular Benefit to TZDs? Examining the Evidence 1.5 AMA/PRA
Hypertension, Nitric Oxide, and Beta-Blockade 0.5 AMA/PRA
The Patient With Mixed Hyperlipidemia .5 AMA PRA
Evidence to Support Aggessive Management of HDL-C:
Implications of Recent Trails 1.0 AMA PRA
________________________
Continuing Medical Education Credits completed 2007
Atrial Fibrillation: Diagnosis and Management 1.0 AMA/PRA
Stress (Takotsubo) Cardiomyopathy -- A Novel Pathophysiological Hypothesis to Explain
Catecholamine-induced Acute Myocardial Stunning 1.0 AMA/PRA
Understanding Triglycerides: Beyond LDL Cholesterol 0.25 AMA/PRA
Low-Dose Aspirin Linked to Lower Risk for All-Cause Mortality in Women 0.25 AMA/PRA
Low-Dose Aspirin Best for CVD Prevention 0.25 AMA/PRA
Dietary Soy May Improve Features of Metabolic Syndrome in Postmenopausal Women 0.25 AMA/PRA
US Dietary Guidelines Effectively Limit Insulin Resistance in Women 0.25 AMA/PRA
AHA Guidelines for CVD Prevention in Women Focus on Lifetime Risk Factors 0.25 AMA/PRA
Above-Optimal CVD Risk Factors Measured Early in Life Predictive of Future Disease 0.25 AMA/PRA
Hypertension Highlights: World Hypertension Day, ACC.07, and RAAS Inhibition 1.0 AMA/PRA
Nonpharmacologic Management of Osteoporosis to Minimize Fracture Risk 1.0 AMA/PRA
Breaking Barriers Not Bones: Evolving Concepts in Understanding & Managing Osteoporosis 1.0
AMA/PRA
Exercise, Calcium Supplementation May Improve BMD in Postmenopausal Women 0.25 AMA/PRA
Four-Item Score May Predict Hip Fracture, Mortality Risk in Elderly Women 0.25 AMA/PRA
FDA Approves Lybrel for Continuous Contraception 0.25 AMA/PRA
Beginning Oral Contraceptives Before Start of Next Menses May Improve
Compliance for Short Term 0.25 AMA/PRA
Specific Symptoms May Assist in Early Detection of Ovarian Cancer 0.25 AMA/PRA
Low-Dose Combination Oral Contraceptives Protect Against Ovarian Cancer 0.25 AMA/PRA
Hormone Replacement Therapy Linked to Ovarian Cancer 0.25 AMA/PRA
Healthy Diet May Not Reduce Breast Cancer Recurrence or Mortality 0.25 AMA/PRA
Contraception for a Woman With a History of Fibroids: An Interactive Case 0.75 AMA/PRA
Therapy Insight: Guidelines for Selection of Contraception in Women with
Rheumatic Diseases 1.0 AMA/PRA
Screening for Maternal Depression: An Opportunity for Providers
of Pediatric Healthcare 1.0 AMA/PRA
Urinary Tract Infections: A Primer for Clinicians 1.0 AMA/PRA
Updated Statement on Hormone Therapy 0.25 AMA/PRA
Ground Rounds: Encouraging More Patients to Choose and IUD 1.0 AMA/PRA
Management of Dysmenorrhea 1.0 AMA PRA
The Premenstrual Continuum: Improving Diagnosis and Treatment 1.0 AMA PRA